Status:
COMPLETED
Antidepressant Incomplete Response Depression
Lead Sponsor:
AstraZeneca
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
Observational, non-interventional, longitudinal, prospective,multicenter, open label (No treatment is involved). 3 assessment will be carried out . The 1st one will be on baseline, the 2sd one after a...
Eligibility Criteria
Inclusion
- Provision of written inform consent
- Diagnosed of Major Depressive Disorder based on DSM-IV-TR
- Outpatient who has a change in pharmacological therapeutic plan after an incomplete response or intolerance to a treatment with an adequate dosage of an antidepressant (SSRI/NSRI) 5
- Able to understand and to comply with requirements of the study
Exclusion
- Mental retardation
- To have been recruited in a clinical trial in the last 4 weeks or to have planned the inclusion in a clinical trial during the follow-up of this study
- MDD secondary to substance abuse or somatic illness
- Actual depressive episode with \<4 weeks or \>12 months of length
- Current treatment with \>1 SSRI/SRNI or previous treatment with \>1 SSRI/SRNI, augmentation treatment with SSRI/SRNI, intravenous antidepressant treatment, TMS, ECT or MAO
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT00782964
Start Date
October 1 2008
End Date
November 1 2009
Last Update
December 24 2009
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Albacete, Albacete, Spain
2
Research Site
Alcoy, Alicante, Spain
3
Research Site
Benidorm, Alicante, Spain
4
Research Site
Villajoyosa, Alicante, Spain